The UW-CryoEM group studies the structures of high-value viral macromolecular complexes involved in the pathogenesis of NIAID Category A-C organisms, with the long-term goal to provide a structural framework for vaccine and/or therapeutic design aiming at preventing or neutralizing infections mediated by these human pathogens.
UW-CryoEM Site Team
David Veesler, Ph.D., Co-Principal Investigator and Director, UW CryoEM
Dr. Veesler will lead the efforts of the UW CryoEM
@UWproteindesign
The University of Washington’s Institute for Protein Design has become a hub to galvanize de novo protein engineeri… https://t.co/aqFbeqLkXO
2 weeks, 1 day ago
@veeslerlab
Our study of the S309 SARS-CoV-2 neutralizing antibody is featured in the @sfchronicle (thank you @CDizikes). Clini… https://t.co/bbMILL2rtB
3 weeks, 6 days ago
@BIOVentures
Read this month's #WIPOResearch Snapshot about human African trypanosomiasis #HAT and Dr. Kande's discovery of the… https://t.co/nVfJT8YU8h
4 weeks ago
